DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20181431

Significance of abdominal manifestations in dengue fever

R. Jaya Prakash Reddy, P. Vijaya Narasimha Reddy

Abstract


Background: Dengue Fever is an Infectious condition caused by flavo virus. It is an epidemic since 4 years and its prevalence is increased in the recent years in India. The increase in India is due to rapid urbanization, population growth, increased international travel and global warming. But dengue fever is now being reported from rural backgrounds due to poor sanitation and stagnant water sources.

Methods: This is an institutional cross sectional study in which we took patients presenting with fever and various other complaints related to viral fevers for 9months from 2016 June to March 2017 at Rajiv Gandhi Institute of Medical Sciences, Ongole. In this study we included patients who are NS1 Ag positive and dengue ELISA positive only. We excluded whose NS1 Ag test positive but their dengue IgM ELISA report is negative.

Results: In this study we have included 94 patients of all age groups who are diagnosed with dengue fever. Next in the list are nausea/vomiting (43.6%) and diarrhea (40.4%) respectively. We highlighted this in conclusion to consider abdominal manifestations association while evaluating pyrexia patients.

Conclusions: As usually fluid management and regular monitoring is the main role in the management of dengue cases than platelet or blood transfusions and antibiotics. We concluded that there is significant association between abdominal manifestations and dengue fever. So abdominal manifestations should be considered while evaluating pyrexia patients to rule out dengue association in those patients and prognosis of dengue fever.


Keywords


Abdominal manifestations, Diarrhea, Dengue fever, Gall bladder wall thickening

Full Text:

PDF

References


Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's principles of internal medicine, 19e. 2015;2:1319-20.

Munjal YP, Sharm SK. API Textbook of Medicine. JP Medical Ltd; 9th Edi. 2012;2:1158-160.

WHO. Scientific working group report on dengue. Geneva, Switzerland: WHO;2007:35-6.

Mohan D K, Shiddappa, Dhananjaya M. A study of clinical profiles of dengue fever I a tertiary care teaching hospital. Sch J APP Med Sci. 2013;1:280-2.

Munde DD, Shetkar UB. Clinical features and haematological profile of dengue fever. India J Appl Res. 2013;3:131-2.

TDR/WHO. Evaluation of commercially available anti-dengue virus immunoglobulin M tests. diagnostics evaluation series No-3 Geneva. Switzerland: TDR/WHO;2009.

Mittal H, Farida MM, Arora SK, Patil R. Clinicohematological profile and platelet trends in children with dengue during 2010 epidemic in north India. Indian J Pediatr. 2012;79(4):467-71.

Mandal SK, Ganguly J, Sil K, Chatterjee S, Chatterjee K, Sarkar P, et al. Clinical profiles of dengue fever in a teaching hospital of eastern India. Nat J Med Res. 2013;3:173.

Rahim MA, Sikder MS. Clinicopathologic manifestations and outcome of dengue fever and dengue haemorrhagic fever. Bangladesh Med Res Counc Bull. 2005;31(1):36-45.

Parmar JP, Mohan C, Vora M. Patterns of gall bladder wall thickening in dengue fever: A mirror of the severity of disease. Ultrasound international open. 2017;3(2):E76.